Status:
UNKNOWN
Magneto-rheology to Lower Blood Pressure
Lead Sponsor:
Cardiovascular Therapy LLC
Conditions:
Hypertension
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Heart attacks and strokes are the leading causes of death in US. High blood viscosity and turbulence in blood flow are the key for cardiovascular diseases. Recent research has shown that application o...
Detailed Description
GOAL: Conduct pivotal clinical trials with Magnetic Blood Pressure Lowering (MBPL) Device, developed in this lab, to see how effective it can lower patients' high blood pressure. The pilot study has c...
Eligibility Criteria
Inclusion
- The systolic blood pressure in a range of 140-180 mmHg or diastolic blood pressure in a range 90-120 mmHg.
Exclusion
- Subjects with a pacemaker or other metallic devices implanted.
- Adults unable to consent,
- Cognitively impaired adults,
- Pregnant women,
- Prisoners.
Key Trial Info
Start Date :
August 10 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03783117
Start Date
August 10 2018
End Date
August 31 2019
Last Update
December 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Magnetic Blood Pressure Lowering Device Study
Philadelphia, Pennsylvania, United States, 19122